D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
NXTC holding history
NextCure, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NXTC overviewAll 13F holders of NXTCFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −13,860−100.0% | Sold out | Holders |
| Q4 2022 | 13,860 | $19.5K | <0.1% | +13,860 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −12,776−100.0% | Sold out | Holders |
| Q3 2021 | 12,776 | $86.0K | <0.1% | −24,224−65.5% | Reduced | Holders |
| Q2 2021 | 37,000 | $297.0K | <0.1% | −7,352−16.6% | Reduced | Holders |
| Q1 2021 | 44,352 | $444.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.